[#DIV28SUPER] Fwd: [SCIENCECHANNEL] PCORI New Funding Opportunities

FYI

Begin forwarded message:

From: "Prinstein, Mitch" <MPrinstein@apa.org>

Subject: [SCIENCECHANNEL] PCORI New Funding Opportunities

Date: August 31, 2021 at 3:56:14 PM EDT

To: SCIENCECHANNEL@LISTS.APA.ORG

Reply-To: Forum for urgent science needs with the APA Science and Advocacy Offices <SCIENCECHANNEL@LISTS.APA.ORG>

      External Email - Use Caution      

New Funding Opportunities Open in September  On September 7, PCORI will begin accepting applications through our Phased Large Awards for Comparative Effectiveness Research (PLACER) PCORI Funding Announcement (PFA) totaling up to $200 million. This PFA offers funds to support large, multiphase comparative clinical effectiveness research (CER) studies designed to fill critical gaps in evidence and support healthcare decision making. Prospective applicants are invited to attend a September 10 town hall for more information.   PCORI is also accepting applications through several Broad PFAs for CER studies aligned with our current National Priorities, offering a cumulative total of $72 million. Within these opportunities, new special areas of focus will include telehealth for chronic disease management among vulnerable populations and addressing systemic racism, discrimination, and bias in healthcare systems and healthcare delivery. Prospective applicants are invited to attend a September 8town hall for more information.   In addition, PCORI will consider proposals through an Implementation PFA for projects that aim to implement CER results generated by PCORI-funded studies in real-world practice settings, moving evidence toward practical use in improving health care and health outcomes.   More about these funding opportunities

 

Click on this link to unsubscribe from the SCIENCECHANNEL list UNSUBSCRIBE

An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list.

[#DIV28SUPER] Manuscript Requests for Frontiers Collection on Stimulant-Opioid Co-Use Epidemic

Dr's Justin Strickland, Saeed Ahmed, and Kelly Dunn invite you to submit an article to a special collection of Frontiers in Psychiatry, Addictive Disorders titled "A Changing Epidemic and the Rise of Opioid and Stimulant Co-Use".

We aim to develop a multi-disciplinary collection that will inform the co-use of stimulants such as methamphetamine and cocaine with opioids. All related science is welcome and we particularly encourage submissions in the following areas

• Electrophysiological data
• Animal behavioral studies
• Human empirical studies
• Epidemiological reports of prevalence, morbidity, mortality, or co-use patterns
  
• Related commentaries or reviews
  

Initial submissions are due September 29, 2021 (with opportunity to extend submission deadline upon discussion with co-editors). More information and the submission portal can be accessed here: https://www.frontiersin.org/research-topics/20614  and we can be contacted at the addresses below.

Warm regards,

Justin Strickland, Ph.D.: jstric14@jhmi.edu

Kelly Dunn, Ph.D., MBA: kdunn9@jhmi.edu

Saeed Ahmed, M.D.: ahmedsaeedmd@gmail.com

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] Interesting article!

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782842?guestAccessKey=69c6ff60-1346-4f71-bbb2-24d7e9a42e2e&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=olf&utm_term=081121 

FYI, Carl Tishler, Ph.D., ABPP 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[DIV28ANNOUNCE] Division 28 Newsletter -- Summer 2021

Dear Division 28,  

 

I hope you are all doing well! Attached please find the latest issue of the Division 28 Newsletter.​ This newsletter contains up to the minute details of our APA convention program including free live events happening this Friday. We hope you will join us!

 

Warm wishes,  

Meredith (Division 28 Newsletter Editor) 

_______________________________

Meredith S. Berry, Ph.D.

Assistant Professor

Department of Health Education and Behavior

Department of Psychology

University of Florida

Gainesville, Florida 32611

Email: mberry@ufl.edu

[#DIV28SUPER] Call for Papers for Special Issue of Psychology of Addictive Behaviors: "Addictive Behavior as Behavioral Allocation"

Call for Papers for Special Issue of Psychology of Addictive Behaviors on

“Addictive Behavior as Behavioral Allocation”

 

Guest Editor Jalie A. Tucker with Associate Guest Editors Joanna Buscemi,

James G. Murphy, and Derek D. Reed

 

Fifty years ago basic science research on behavioral choice fomented a revolution in reinforcement theory by showing that any voluntary behavior can be fruitfully studied as choice arising out of a context of all possible behaviors and associated environment constraints. As epitomized by the pioneering work of psychologist Howard Rachlin, research on behavior patterns over time in relation to available activities in the surrounding environment demonstrated that preference for a given activity varies with constraints on its access and on the other alternatives, and strength of preference for an activity is measured by the relative amount of resource (e.g., time, effort, money) allocated to gain access to it. This molar level of analysis relating rates of behavior to rates of consequences over time laid the foundation for the emergence of behavioral economics in the 1980s, and seminal applied connections were soon made between the molar choice perspective, behavioral economics, and the analysis of substance use in humans. This work has continued to the present and has expanded to include other addictive and health behaviors.

 

This special issue, dedicated to Howard Rachlin who died in 2021, honors his work and recognizes his influence on applied research on addictive behaviors, the initial area of application and arguably the most successful to date. Manuscripts are sought in all areas of research on human addictive behaviors spanning the basic to applied continuum that aim to understand addictive behavior as molar behavior allocation patterns over time. Conceptual, empirical, and methodological contributions that advance applied research on addictive behaviors and inform positive behavior change at the individual or community level will be considered. For example, papers may focus on the behavioral economics or neuroeconomics of addictive behaviors; choice behavior and decision-making processes; choice biases and choice architecture in strategies to reduce addictive behavior; intervention approaches informed by behavioral economics or theories of choice; natural recovery from addictive behavior patterns; measurement approaches in laboratory and natural environments; quantitative methods for representing and analyzing data on behavioral patterning over time; social cooperation and interactions with addictive behaviors; and unresolved and under-developed conceptual and empirical issues in the field. Papers that contextualize individual choice behavior within broader community and policy environments and consider social determinants of health will be given favorable consideration.

We will consider full-length articles and brief reports that present on original research and scholarship. All submissions must adhere to journal guidelines and will undergo peer review. The special issue article type will be open to submissions on August 10, 2021 with a deadline for manuscript submission on February 15, 2022. Prior to submitting a manuscript, authors are asked to submit a brief letter of intent to Guest Editor Dr. Jalie A. Tucker (jaliet@ufl.edu).

 

For more information about the journal submission process, please visit https://www.apa.org/pubs/journals/adb

 

 

Katie Witkiewitz, PhD

Editor, Psychology of Addictive Behaviors

Regents’ Professor, Department of Psychology

Center on Alcohol, Substance Use, And Addictions (CASAA)

University of New Mexico

Logan Hall, Room 118

MSC 03-2220

Albuquerque, NM 87131

Lab website: https://abqresearch.org

Pronouns: She/Her/Hers 

 

 

[#DIV28SUPER] Don't forget - Register for the APA Division 28 Live Event - FRIDAY August 13th, 2021 1-3 ET

​Register for the FREE live event here: https://jhmi.co1.qualtrics.com/jfe/form/SV_blwcEmYRaPk9qVU

Register for the Annual Convention here: https://convention.apa.org/

Cecilia Bergeria, Ph.D.

Assistant Professor

Behavioral Pharmacology Research Unit

Department of Psychiatry and Behavioral Sciences

Johns Hopkins University School of Medicine

P: 410-550-1979

[#DIV28SUPER] NIDA Neuroscience Update August 9, 2021

Table of Contents

I.          Call for Application for Early Career Investigator Showcase (ECIS) Award

Due September 10, 2021, 5:00 PM EDT

II.     RFA-DA-22-031 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 - Clinical Trial Not Allowed)  https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-031.html Application due date: October 19, 2021 due by 5:00 PM local time of applicant organization.

III.  RFA-DA-22-032 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 - Clinical Trial Not Allowed)  https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-032.html Application due date: October 19, 2021 due by 5:00 PM local time of applicant organization.

IV.  NOT-DA-20-030 Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-030.html Application Due Dates:   Standard Due Dates Apply.

 

---------

 

I.          Call for Application for Early Career Investigator Showcase (ECIS) Award

Due September 10, 2021, 5:00 PM EDT

 

The 2021 NIDA-NIAAA Mini-Convention is now soliciting applications for the Early Career Investigator Showcase (ECIS) award. Applicants should be trainees or junior investigators who meet the definition of a NIH New Investigator/Early Stage Investigator [NI/ESI] of being within 10 years of completing a terminal research degree or medical residency [http://grants.nih.gov/grants/new_investigators/].  Eight (8) individuals will be selected for this symposium. Individuals selected for ECIS will be chosen for the quality of their research and its relevance to the missions of NIDA or NIAAA, or to the themes of the scientific sessions of the Mini-Convention. ECIS participants are expected to prepare both a virtual poster presentation of their research that will be available to attendees during the Mini-Convention and an 8-minute oral presentation that briefly describes the research. 

To apply, please complete the application form, include your Curriculum Vitae/Resume and list of publications, and send via email (to ECIS.Abstracts@seiservices.com) by Friday, September 10, 2021 5:00 PM (EDT). To consider your application, you must select only one Institute on the form. Abstracts accepted for the 2021 SfN Virtual Meeting may be submitted for presentation at ECIS. All applicants will be notified of the status of their submission by Friday, October 8, 2021. For additional information, please contact: for NIDA [Anne Tsai, stsai@nih.gov] or for NIAAA [John Matochik, jmatochi@mail.nih.gov].

 

---------------

II.  RFA-DA-22-031 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 - Clinical Trial Not Allowed)  https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-031.html Application due date: October 19, 2021 due by 5:00 PM local time of applicant organization.    

 

This funding opportunity announcement aims to support research focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent or treat opioid use disorders (OUDs), opioid overdose, and opioid-polysubstance use comorbidities. This announcement is specifically focused on identification of novel targets and early preclinical development of small molecules and biologics. Emphasis is on the identification of drug targets and validation through development of probe molecules to modulate those targets.

---------------------

 

III.  RFA-DA-22-032 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 - Clinical Trial Not Allowed)  https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-032.html Application due date: October 19, 2021 due by 5:00 PM local time of applicant organization.

This funding opportunity announcement aims to support research focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent or treat opioid use disorders (OUDs), opioid overdose, and opioid-polysubstance use comorbidities. This announcement is specifically focused on identification of novel targets and early preclinical development of small molecules and biologics. Emphasis is on the identification of drug targets and validation through development of probe molecules to modulate those targets.

 

--------------

IV.  NOT-DA-20-030 Notice of Special Interest (NOSI): Human Molecular Genetics of Substance Use Disorders https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-030.html Application Due Dates:   Standard Due Dates Apply.

This Notice encourages applications for research projects that identify, validate and/or functionally characterize loci, genetic variations and haplotypes that are associated with vulnerability to addiction and that potentially inform the likelihood of responsiveness to treatment. Data may be collected from the general population, special populations, recent admixed populations, and/or electronic medical records (EMR). Secondary data analysis of data collected from the general population, special populations, recent admixed populations, and/or animal models is also appropriate for this notice. Investigators are encouraged to include functional characterization, gene x gene interactions, gene x environment interactions, and gene x environment x development interactions.

-------------------

 The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-

 

 

[#DIV28SUPER] Advocacy priority related programming at APA convention

Dear Colleagues-

As a member of the APA Advocacy Coordinating Committee (ACC), I'd like to share with you a list of 2021 APA Convention programming that the ACC has identified which aligns with the 18 APA advocacy priorities.

The attached PDF provides the number and title of these sessions.

-Bill Stoops.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Reminder Call for Papers: Experimental and Clinical Psychopharmacology Special Issue

Reminder Call for Papers: Experimental and Clinical Psychopharmacology (Due: Oct 1, 2021)

Special Issue on Crowdsourcing Methods in Addiction Science: Emerging Research and Best Practices 

This Special Issue will assemble a collection of papers on best practices and emerging research using crowdsourcing for addiction science. With the changing landscape of work amidst the global COVID-19 pandemic and increasing costs associated with collecting large participant samples, addictions researchers are increasingly turning to alternative methods for recruiting participants and collecting data. Crowdsourcing platforms—such as Amazon Mechanical Turk, Prolific, and Qualtrics Panels—have become a dominant form of sampling in recent years. These crowdsourcing platforms allow researchers to continue to collect data from large samples of human participants when face-to-face visits are challenging, cost-prohibitive, or infeasible (e.g., research sites at logistically prohibitive distances, social distancing requirements during COVID-19). Alongside optimism about the practical benefits that crowdsourcing may provide are uncertainties about the validity of these Internet-based approaches and how they can (and cannot) be used. Any articles addressing the use of crowdsourcing in addictions science are welcome, but three areas are of specific interest. First, the issue aims to provide an historical and contemporary overview of available crowdsourcing platforms and how these have been used in addiction and behavioral science research. Second, innovative examples of original research studies will be included to illustrate the unique promise of crowdsourcing. The third area of emphasis involves the potential pitfalls of using this technology for data collection and methods to ensure that data are reliable and valid. Taken together, the overarching goal of this Special Issue is to highlight best practices for using crowdsourcing in addiction science while also drawing attention to important methodological and conceptual limitations of this methodology. 

We encourage submission of review articles and original research reports in these areas, including novel strategies or methodological advances in crowdsourcing research in addictions. Papers addressing a variety of substances, including alcohol, tobacco, cannabis, and other drugs, as well as behavioral addictions are welcome. Researchers in this area may submit their manuscripts to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue: Crowdsourcing Methods in Addiction Science: Emerging Research and Best Practices. All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2021 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft title and abstract. 

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Justin Strickland, PhD, at jstric14@jhmi.edu, Michael Amlung, PhD, at mamlung@ku.edu, or Derek Reed, PhD, at dreed@ku.edu, or the Editor, William W. Stoops, PhD at William.stoops@uky.edu. 

 

 

 

 

---------------------------------------------------------
Justin C. Strickland, Ph.D.
Instructor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Phone: (410) 550-1975

He/him/his

 

 

[#DIV28SUPER] job posting for research assistant position in Baltimore, MD

We are seeking a FT post-baccalaureate research assistant for an NIH-funded project in Baltimore, MD.

 

https://sjobs.brassring.com/TGnewUI/Search/home/HomeWithPreLoad?PageType=JobDetails&partnerid=25752&siteid=5541&AReq=19776BR#jobDetails=4317930_5541

 

Please send inquiries to: ryi1@ku.edu

 

Richard Yi, Ph.D.

Director, Cofrin Logan Center for Addiction Research and Treatment

Professor, Department of Psychology

University of Kansas, Lawrence, KS 66045

Email: ryi1@ku.edu          Phone: 785-864-6476

https://addiction.ku.edu

 

 

Re: [#DIV28SUPER] Research Participation

Could the owner of the list confirm this?

I am in a several divisions and no division has had a problem with this request including Divisions 35, 28, and 42. 

—

La Keita D. Carter, PsyD

Owner/CEO

Licensed Psychologist (MD)

Licensed Clinical Professional Counselor-Supervisor

Institute for HEALing, LLC

9419 Common Brook Road Suite 208 

Owings Mills, MD 21117

(410) 864-0211 (Phone & Fax)

DrLDCarter@myiHEAL.com

On Aug 4, 2021, at 8:09 AM, Carl Tishler, Ph.D. ABPP <tishlerc@gmail.com> wrote:



At least on other listserv formats (div53) utilizing the list for research purposes is prohibited. 

Carl Tishler, Ph.D., ABPP 

On Tue, Aug 3, 2021, 12:36 PM LaKeita Carter, PsyD <drldcarter@myiheal.com> wrote:

Hi Everyone,

My practice is running research on relationships and sexual health. Would you be so kind as to complete these two surveys? Also, if you could pass along this email or the links to students and colleagues or post them on your social media pages or classrooms, that would be great!

Cheating Behavior (2 minutes)

https://www.research.net/r/cheating721div28

 

Marital Satisfaction (4 minutes)

https://www.research.net/r/maritalsat721div28 

 

Mahalo!

La Keita D. Carter, PsyD

Owner/CEO

Licensed Psychologist (MD)

Licensed Clinical Professional Counselor-Supervisor (MD)

Licensed Clinical Alcohol & Drug Counselor (MD)

Diplomate, American Academy of Experts in Traumatic Stress (DAAETS)

Certified Clinical Trauma Professional (CCTP)

Notary Public

Where healing happens

-------

Institute for HEALing, LLC

9419 Common Brook Road   |   Suite 208

Owings Mills, MD 21117

www.myiHEAL.com   |   DrLDCarter@myiHEAL.com

(410) 864-0211 Ext. 0 (Phone)

(410) 618-4163 (Fax)

Zoom Treatment Room: https://myiheal.zoom.us/my/drldcarter 

Calendly: https://calendly.com/drldcarter

IMPORTANT WARNING: This e-mail is intended for the use of the person to whom it is addressed and may contain information that is privileged and confidential, the disclosure of which is governed by applicable law. If the reader of this e-mail is not the intended recipient, or the employee or agent responsible to deliver it to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this information is STRICTLY PROHIBITED. If you have received this message in error, please notify us immediately and delete the related e-mail.

HIPAA PROTECTED HEALTH INFORMATION WARNING: Please be aware that email communication can be intercepted in transmission or misdirected. Your use of email to communicate protected health information to us indicates that you acknowledge and accept the possible risks associated with such communication. Please consider communicating any sensitive information by telephone, fax or mail. If you do not wish to have your information sent by email, please contact the sender immediately.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] Research Participation

At least on other listserv formats (div53) utilizing the list for research purposes is prohibited. 

Carl Tishler, Ph.D., ABPP 

On Tue, Aug 3, 2021, 12:36 PM LaKeita Carter, PsyD <drldcarter@myiheal.com> wrote:

Hi Everyone,

My practice is running research on relationships and sexual health. Would you be so kind as to complete these two surveys? Also, if you could pass along this email or the links to students and colleagues or post them on your social media pages or classrooms, that would be great!

Cheating Behavior (2 minutes)

https://www.research.net/r/cheating721div28

 

Marital Satisfaction (4 minutes)

https://www.research.net/r/maritalsat721div28 

 

Mahalo!

La Keita D. Carter, PsyD

Owner/CEO

Licensed Psychologist (MD)

Licensed Clinical Professional Counselor-Supervisor (MD)

Licensed Clinical Alcohol & Drug Counselor (MD)

Diplomate, American Academy of Experts in Traumatic Stress (DAAETS)

Certified Clinical Trauma Professional (CCTP)

Notary Public

Where healing happens

-------

Institute for HEALing, LLC

9419 Common Brook Road   |   Suite 208

Owings Mills, MD 21117

www.myiHEAL.com   |   DrLDCarter@myiHEAL.com

(410) 864-0211 Ext. 0 (Phone)

(410) 618-4163 (Fax)

Zoom Treatment Room: https://myiheal.zoom.us/my/drldcarter 

Calendly: https://calendly.com/drldcarter

IMPORTANT WARNING: This e-mail is intended for the use of the person to whom it is addressed and may contain information that is privileged and confidential, the disclosure of which is governed by applicable law. If the reader of this e-mail is not the intended recipient, or the employee or agent responsible to deliver it to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this information is STRICTLY PROHIBITED. If you have received this message in error, please notify us immediately and delete the related e-mail.

HIPAA PROTECTED HEALTH INFORMATION WARNING: Please be aware that email communication can be intercepted in transmission or misdirected. Your use of email to communicate protected health information to us indicates that you acknowledge and accept the possible risks associated with such communication. Please consider communicating any sensitive information by telephone, fax or mail. If you do not wish to have your information sent by email, please contact the sender immediately.

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Join us for Division 28 LIVE PROGRAMMING on Friday, August 13 from 1:00-3:00 EST

​Greetings colleagues,

We are less than 2 weeks away from the APA convention! Please block your calendars on Friday, August 13 from 1:00-3:00 EST to attend our live Division 28 programming- we will be discussing our strategic plan and we need your input and feedback! We will then reconvene from 4:00-6:00 EST to support our early career investigators. Both events are free but require preregistration.

----------------------------------------------------------------------------------------------

1:00-3:00 EST Division 28 Live programming (approximate schedule below, register for free here: https://jhmi.co1.qualtrics.com/jfe/form/SV_blwcEmYRaPk9qVU)

1:00-2:00, Division 28 Awards and Data Blitz (see detailed brochure at the bottom of this email)

2:00-3:00, Presidential Lecture "How Will You Benefit from Division 28's Five Year Strategic Plan" followed by short business meeting (please review business minutes from last year here: https://tinyurl.com/Div282020BusinessMeeting).

----------------------------------------------------------------------------------------------

4:00 - 6:00 EST NIAAA and NIDA Early Career Investigator Poster Session and Social Hour sponsored jointly by NIDA and NIAAA (register for free here: https://redcap.partners.org/redcap/surveys/?s=WYM8LPWAMA)

4:00-4:15: Opening remarks

4:15-5:00: Poster presenter group A + discussions

5:00-5:45: Poster presenter group B + discussions

5:45-6:00: Closing remarks

The brochure and more detailed descriptions of talks are available here : https://scholar.harvard.edu/files/bettina.hoeppner/files/apa_2021_brochure

----------------------------------------------------------------------------------------------

Finally, please plan to register for the Annual Convention here: https://convention.apa.org/

----------------------------------------------------------------------------------------------

Warmest regards,

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

---

 

​Register for the FREE live event here: https://jhmi.co1.qualtrics.com/jfe/form/SV_blwcEmYRaPk9qVU

Register for the Annual Convention here: https://convention.apa.org/

Cecilia Bergeria 

Division 28 Program Chair

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28